The use of si-MALAT-1 resulted in an elevation of E-cadherin expression, a reduction in β-catenin expression mediated by Ezh2, and subsequently led to decreased proliferation and invasion of RCC cells. This evidence concerns the gene MALAT1 and renal cell carcinoma.